A carregar...
Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor
In this article, we propose, based on a clinical case, the potential antitumor effect related to the inhibition of serotonin in neuroendocrine tumors (NETs). Currently, the only drug that exists for the symptomatic treatment of carcinoid syndrome refractory to somatostatin analogues is telotristat,...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656452/ https://ncbi.nlm.nih.gov/pubmed/30877189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0776 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|